|
||
J. Cell Biol.,
Volume 145, Number 4, May 17, 1999 851-863

* Department of Anatomy and Cell Biology, State University of New York, Health Science Center, Syracuse, New York 13210; Paxillin is a focal adhesion adaptor protein
involved in the integration of growth factor- and adhesion-mediated signal transduction pathways. Repeats of
a leucine-rich sequence named paxillin LD motifs
(Brown M.C., M.S. Curtis, and C.E. Turner. 1998. Nature Struct. Biol. 5:677-678) have been implicated in
paxillin binding to focal adhesion kinase (FAK) and
vinculin. Here we demonstrate that the individual paxillin LD motifs function as discrete and selective protein binding interfaces. A novel scaffolding function is
described for paxillin LD4 in the binding of a complex
of proteins containing active p21 GTPase-activated kinase (PAK), Nck, and the guanine nucleotide exchange
factor, PIX. The association of this complex with paxillin is mediated by a new 95-kD protein, p95PKL (paxillin-kinase linker), which binds directly to paxillin LD4
and PIX. This protein complex also binds to Hic-5, suggesting a conservation of LD function across the paxillin superfamily. Cloning of p95PKL revealed a multidomain protein containing an NH2-terminal ARF-GAP
domain, three ankyrin-like repeats, a potential calcium-binding EF hand, calmodulin-binding IQ motifs, a myosin homology domain, and two paxillin-binding subdomains (PBS). Green fluorescent protein- (GFP-) tagged
p95PKL localized to focal adhesions/complexes in
CHO.K1 cells. Overexpression in neuroblastoma cells
of a paxillin LD4 deletion mutant inhibited lamellipodia formation in response to insulin-like growth fac-
tor-1. Microinjection of GST-LD4 into NIH3T3 cells
significantly decreased cell migration into a wound. These data implicate paxillin as a mediator of p21
GTPase-regulated actin cytoskeletal reorganization
through the recruitment to nascent focal adhesion
structures of an active PAK/PIX complex potentially via interactions with p95PKL.
Department of Molecular Medicine, Cornell University, Ithaca, New York 14853; and § Department of Medicine, Beth Israel
Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215
This article has been cited by other articles:
|
|